MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/jmv.29432

Медицинская библиотека · Journal of medical virology · 2024

Non-liver-related mortality in the DAA era: Insights from post-SVR patients with and without previous HCC history.

Miuma Satoshi, Miyaaki Hisamitsu, Ichikawa Tatsuki, Matsuzaki Toshihisa, Goto Takashi, Kamo Yasuhiro, Shigeno Masaya, Hino Naoyuki, Ario Keisuke, Yanagi Kenji, Tsutsumi Takuya, Fukushima Nobuyoshi, Nakashiki Suguru, Yamasaki Kazufumi, Hamasaki Keisuke, Shibata Hidetaka, Arima Kazuhiko, Yamamichi Shinobu, Yamashima Mio, Takahashi Kosuke, Nakao Yasuhiko, Fukushima Masanori, Haraguchi Masafumi, Sasaki Ryu, Ozawa Eisuke, Taura Naota, Nakao Kazuhiko

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND AND AIMS: Mortality after sustained virological response (SVR) with interferon-free direct-acting antiviral (IFN-free DAA) therapy is crucial for optimizing post-SVR patient care, but it remains unclear, especially regarding non-liver-related mortality.

METHODS

Consecutive post-SVR patients from 14 institutions were stratified into three cohorts: A (without advanced fibrosis and without prior HCC), B (with advanced fibrosis and without prior HCC), and C (curative HCC treatment). We assessed mortality (per 1000 person-years [/1000PY]) post-SVR. Mortality rates were compared between cohorts A and B and the general population using age- and sex-adjusted standardized mortality ratio (SMR). Comparison of survival between each cohort was performed using propensity-score (PS) matching with sex, age, and comorbidity.

RESULTS

In cohort A (n = 762; median age, 65 years), 22 patients died (median follow-up, 36 months); all-cause mortality was 10.0/1000PY, with 86.4% non-liver-related deaths. In cohort B (n = 519; median age, 73 years), 27 patients died (median follow-up, 39 months); all-cause mortality was 16.7/1000PY, with 88.9% non-liver-related deaths. In both cohorts, malignant neoplasm was the most common cause of death; all-cause mortality was comparable to that of the general population (SMR: 0.96 and 0.92). In cohort C (n = 108; median age, 75 years), 15 patients died (median follow-up, 51 months); all-cause mortality was 36.0/1000PY, with 53.3% liver-related deaths. PS matching showed no significant survival differences between cohorts A and B, both of which had better survival than cohort C.

CONCLUSIONS

Mortality varies based on HCC history in the DAA era; nevertheless, attention should be paid to non-liver-related deaths in all post-SVR patients.

Для цитирования: Miuma Satoshi, Miyaaki Hisamitsu, Ichikawa Tatsuki, Matsuzaki Toshihisa, Goto Takashi, Kamo Yasuhiro, Shigeno Masaya, Hino Naoyuki, Ario Keisuke, Yanagi Kenji, Tsutsumi Takuya, Fukushima Nobuyoshi, Nakashiki Suguru, Yamasaki Kazufumi, Hamasaki Keisuke, Shibata Hidetaka, Arima Kazuhiko, Yamamichi Shinobu, Yamashima Mio, Takahashi Kosuke, Nakao Yasuhiko, Fukushima Masanori, Haraguchi Masafumi, Sasaki Ryu, Ozawa Eisuke, Taura Naota, Nakao Kazuhiko. Non-liver-related mortality in the DAA era: Insights from post-SVR patients with and without previous HCC history.. Journal of medical virology. 2024. DOI: 10.1002/jmv.29432.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.